Agenparl (Itália)

Researchers develop 10-minute COVID-19 diagnostic test that wage workers can afford

Publicado em 03 fevereiro 2021

(AGENPARL) – WORCESTER (MASSACHUSETTS), mer 03 febbraio 2021 (Fundação de Amparo à Pesquisa do Estado de São Paulo) Technology based on nanoparticles identifies IgG antibodies and costs only about a fifth of similar devices now on the market. It was developed by scientists at the University of São Paulo and Brazilian startup Biolinker.